Free Conference on Bone Marrow, Stem Cell and Cord Blood Transplants
Posted on: Tuesday, 20 February 2007, 09:01 CST
Patients diagnosed with leukemia, lymphoma or myelodysplastic syndromes (MDS), along with families and caregivers, are invited to the Third Annual Bone Marrow, Stem Cell, Cord Blood Transplant Conference presented by the Leukemia Research Foundation, with support from The Coleman Foundation, Loyola University Health System and the National Marrow Donor Program (NMDP), Saturday, March 17, from 7:30 a.m. - 2:30 p.m. at The Westin O'Hare in Rosemont, Illinois.
Free continental breakfast, lunch and parking are included with registration at www.leukemia-research.org. The day consists of panel discussions, question and answer, and disease breakout sessions. The complete schedule is as follows:
7:30 a.m. Registration and Continental Breakfast 8:00 Welcome Dr. Patrick Stiff, Loyola University Medical Center 8:10 Umbilical Cord Transplants Dr. Patrick Stiff 8:30 NMDP Overview and New Initiatives Dr. Jeffrey Chell, Chief Executive Officer, NMDP 9:15 Bone Marrow Transplant for Aggressive Lymphomas Dr. Jane Winter, Northwestern Memorial Hospital 9:35 Options for Follicular Lymphoma Dr. Parameswaran Venugopal, Rush University Medical Center 9:55 BREAK 10:15 Bone Marrow Transplant as an Option for CLL Dr. Tulio Rodriguez, Loyola University Medical Center 10:45 BMT as an Option for AML Dr. Wendy Stock, University of Chicago Hospital 11:15 BMT as an Option for MDS Dr. Scott Smith, Loyola University Medical Center 11:45 BREAK 12:00 p.m. Lunch and Patient Panel Panel Moderator: Susan Stewart, BMT InfoNet Panelists include patients and patient caregivers 1:30 Disease-specific breakout sessions Lymphomas, Acute Leukemia, Chronic Leukemia / MDS, Caregivers Moderated by representatives from Loyola University Medical Center, Northwestern Memorial Hospital, Rush University Medical Center, and University of Chicago Hospital
To register, visit www.leukemia-research.org or call 847-424-0600.
The Leukemia Research Foundation, headquartered in Glenview, Ill., is dedicated to funding research and providing support to people affected by blood cancers. The Foundation's mission is to conquer leukemia, lymphoma, and myelodysplastic syndromes by funding research into their causes and cures, and to enrich the quality of life of those touched by these diseases. For 60 years, thousands of volunteers and 24 chapters have helped the Foundation raise more than $39 million to help fund research specifically targeting aspiring, eager, and innovative scientists and physicians around the world.
For information: Carl Alston 847-919-6250 Contact via http://www.marketwire.com/mw/emailprcntct?id=73B1FD275493CDDF
SOURCE: Leukemia Research Foundation
Source: MARKET WIRE
Related Articles
- The African Medical and Research Foundation (AMREF) Honors Merck & Co., Inc. With Global Corporate Philanthropy Award
- Juvenile Diabetes Research Foundation Names The City of Hope a JDRF Islet Cell Transplant Center
- Dallas Stars President James R. Lites and Medical City Dallas Hospital Vice President - Strategic Development Carol Ansley Named Corporate Chairs for the Leukemia & Lymphoma Society's Light the Night Walks
- PhytoMedical and Iowa State University Research Foundation Announce a License Agreement for Novel Synthesized Compounds
- Oklahoma Medical Research Foundation Adds Four Scientists to Faculty
- Leukemia Research Foundation to Host 2nd Annual Conference on Bone Marrow, Stem Cell and Cord Blood Transplants - FREE
- The Fisher Center for Alzheimer's Research Foundation Celebrates 10 Year Anniversary
- Oklahoma Medical Research Foundation Receives $1.8M Award
- Oklahoma Medical Research Foundation Scientists Receive $8 M to Study Flu Vaccine
- SIDMAP Provides Metabolic Phenotyping Services to Researchers at Harvard Medical School's Joslin Diabetes Center and the University of Utah
 |
 |
User Comments (0)
RSS Feeds